Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6–17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial

BACKGROUND: Vaccination of children and young people against SARS-CoV-2 is recommended in some countries. Scarce data have been published on immune responses induced by COVID-19 vaccines in people younger than 18 years compared with the same data that are available in adults. METHODS: COV006 is a ph...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Grace, Cappuccini, Federica, Marchevsky, Natalie G, Aley, Parvinder K, Aley, Robert, Anslow, Rachel, Bibi, Sagida, Cathie, Katrina, Clutterbuck, Elizabeth, Faust, Saul N, Feng, Shuo, Heath, Paul T, Kerridge, Simon, Lelliott, Alice, Mujadidi, Yama, Ng, Khuen Foong, Rhead, Sarah, Roberts, Hannah, Robinson, Hannah, Roderick, Marion R, Singh, Nisha, Smith, David, Snape, Matthew D, Song, Rinn, Tang, Karly, Yao, Andy, Liu, Xinxue, Lambe, Teresa, Pollard, Andrew J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9183219/
https://www.ncbi.nlm.nih.gov/pubmed/35691324
http://dx.doi.org/10.1016/S0140-6736(22)00770-X

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9183219/
https://www.ncbi.nlm.nih.gov/pubmed/35691324
http://dx.doi.org/10.1016/S0140-6736(22)00770-X

Ejemplares similares